Praeparatio cryodesiccata: aripiprazolum 400 mg ut aripiprazolum monohydricum, carmellosum natricum, mannitolum, natrii dihydrogenophosphas monohydricus, natrii hydroxidum, pro vitro corresp. natrium max. 2.2 mg.
Solvens (i.m.): aqua ad iniectabile pro vitro.
Corresp. in solutione recenter reconstituta 200 mg pro 1 mL.
Packungsbestandteile
in solutione recenter reconstituta 200 mg pro 1 mL
in solutione recenter reconstituta 200 mg pro 1 mL
Praeparatio cryodesiccata:
Depot-Injektionssuspension
Active Agent
Dose
Aripiprazole
400 mg
Inactive agents
Carmellose Sodium
Mannitol
Sodium Dihydrogenophosphate Monohydrate
Sodium Hydroxide
Source
Data was imported : 07.07.2023
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
